46
Participants
Start Date
November 30, 2002
Study Completion Date
March 31, 2004
DN-101 (calcitriol)
Roswell Park Cancer Institute, Buffalo
James A. Haley Veterans Hospital, Tampa
Clinical Research Consultants, Inc., Hoover
Boston Baskin Cancer Group, Memphis
The Cleveland Clinic Foundation, Taussig Cancer Center, Cleveland
Rush Cancer Institute MDS Center, Chicago
University of Texas - MD Anderson Cancer Center, Houston
University of California, San Francisco, San Francisco
Oregon Health Sciences University, Portland
Fred Hutchinson Cancer Research Center, Seattle
Lead Sponsor
Novacea
INDUSTRY